|
|
 |
|
Viewing report
|
|
|
|
OTC market in Central and Eastern Europe 2011 - Comparative analysis and development forecasts for 2011-2013
PMR Ltd, Oct 2011, Pages: 341
OTC market in Central and Eastern Europe 2011, Comparative analysis and development forecasts for 2011-2013 is a compilation of data, analysis of current conditions and projections for growth and development for the next two years. This unique report brings readers up to date on the status and prospects of the regional markets as well as for eight specific countries: Bulgaria, the Czech Republic, Hungary, Poland, Romania, Russia, Slovakia and Ukraine.
The document examines the Central and Eastern European market demand for OTC medicines and dietary supplements, as well as market value and share for each by country. It offers in depth information and corporate profiles of producers and wholesalers at work in the region, along with the top-selling products, biggest advertisers and market trends expected to be most influential in the years ahead.
The report’s 300-plus pages contain vital analysis of the structure of product sales, including the most common sales strategies employed both in the regional markets and each country, detailing the variations across the major retail outlets – pharmacy, non-pharmacy and online sales. Regulatory environments and their effect on sales – particularly in the online segment – are described. The preferences of consumers are featured in the report, as well as the facts, statistics, trends and forecasts of the eight countries as their markets expand in the coming years.
This report is essential to the planning and activities of businesses with interests in the region and some or all of the eight included countries. The large coverage area and detailed comparisons supply a huge amount of data, uniquely available at the price savings and with the convenience of a single document. It delves into topics such as production and marketing strategy, market growth potential for specific products in specific countries, and best locations for new product entry, supplying the fundamental coverage required for informed decision making.
|
|
|
|
